:quality(80)/s3.amazonaws.com/arc-authors/morningstar/b76d1412-e5af-4b94-8222-8cb66fe23dbe.jpg)
Adoption of Toric, Multifocal, and Silicon Hydrogel Lenses Boosts Cooper's Top and Bottom Lines
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical.
The Cooper Companies Inc COO
Bulls Say, Bears Say
Bulls
Cooper is one of the leading vision care companies in the world with a proven track record of successful product development and it will continue to launch technically superior products over the long term.
Bears
While the contact lens market share has been stable, lagging research and innovation from Cooper could start to chip away at the company’s presence in the space.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if COO is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $89.93
- Day Range
- $88.77–90.13
- 52-Week Range
- $75.94–104.07
- Bid/Ask
- $85.00 / $88.83
- Market Cap
- $17.66 Bil
- Volume/Avg
- 1.1 Mil / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 26.72
- Price/Sales
- 4.83
- Dividend Yield (Trailing)
- < 0.01%
- Dividend Yield (Forward)
- 0.02%
- Total Yield
- < 0.01%
Company Profile
The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women’s care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Core
- Total Number of Employees
- 15,000
- Website
- https://www.coopercos.com
Competitors
Valuation
|
Metric
|
COO
|
JNJ
|
|---|---|---|
Price/Earnings (Normalized) | 26.72 | 14.07 |
Price/Book Value | 2.29 | 5.14 |
Price/Sales | 4.83 | 4.12 |
Price/Cash Flow | 20.51 | 18.53 |
Price/Earnings
COO
JNJ
Financial Strength
|
Metric
|
COO
|
JNJ
|
|---|---|---|
Quick Ratio | 0.81 | 0.91 |
Current Ratio | 1.86 | 1.16 |
Interest Coverage | 4.77 | 18.88 |
Quick Ratio
COO
JNJ
Profitability
|
Metric
|
COO
|
JNJ
|
|---|---|---|
Return on Assets (Normalized) | 2.49% | 13.98% |
Return on Equity (Normalized) | 3.88% | 35.02% |
Return on Invested Capital (Normalized) | 3.63% | 22.24% |
Return on Assets
COO
JNJ
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Hnzytcmry | Nlxq | $133.1 Bil | |
BDX
| Becton Dickinson & Co | Rvgrmrxpz | Qwgykq | $66.9 Bil | |
ALC
| Alcon Inc | Bylbtjdcg | Rsqffn | $38.9 Bil | |
RMD
| ResMed Inc | Prnqtdnl | Jyhhpn | $32.1 Bil | |
CLPBY
| Coloplast A/S ADR | Mtkjycyzdf | Myty | $27.9 Bil | |
WST
| West Pharmaceutical Services Inc | Xwjfrqqzw | Ppplh | $26.4 Bil | |
BAX
| Baxter International Inc | Vjxjlsgsg | Wkprlw | $20.4 Bil | |
HOLX
| Hologic Inc | Kkqrxsmkn | Ffcpjwh | $17.8 Bil | |
TFX
| Teleflex Inc | Zyfn | Mdrh | $9.7 Bil |